Eukaryotic elongation factor 2 kinase inhibitor, A484954 induced diuresis via nitric oxide production in spontaneously hypertensive rats
Journal of Veterinary Medical Science · 2023
DOI: 10.1292/jvms.23-0306 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Medical Science, 2023. Verfasst von Tomoko Kodama und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Veterinary Pharmacology, School of Veterinary Medicine, Kitasato University, Aomori, Japan. Hauptthemen laut MEDLINE: Elongation Factor 2 Kinase, Nitric Oxide. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Veterinary Pharmacology, School of Veterinary Medicine, Kitasato University, Aomori, Japan.
Zitieren
APA
Kodama, T., Otani, K., Okada, M., & Yamawaki, H. (2023). Eukaryotic elongation factor 2 kinase inhibitor, A484954 induced diuresis via nitric oxide production in spontaneously hypertensive rats. Journal of Veterinary Medical Science. https://doi.org/10.1292/jvms.23-0306
Vancouver
Kodama T, Otani K, Okada M, Yamawaki H. Eukaryotic elongation factor 2 kinase inhibitor, A484954 induced diuresis via nitric oxide production in spontaneously hypertensive rats. Journal of Veterinary Medical Science. 2023. doi:10.1292/jvms.23-0306
BibTeX
@article{Kodama2023,
author = {Kodama, Tomoko and Otani, Kosuke and Okada, Muneyoshi and Yamawaki, Hideyuki},
title = {Eukaryotic elongation factor 2 kinase inhibitor, A484954 induced diuresis via nitric oxide production in spontaneously hypertensive rats},
journal = {Journal of Veterinary Medical Science},
year = {2023},
doi = {10.1292/jvms.23-0306}
}
EUVIMED